Determining the Association between Serum Estradiol Levels on hCG Trigger Day and Live Birth Rates in Non-PCOS Patients | Chapter 3 | Research Developments in Medicine and Medical Science Vol. 8

 This study aims to retrospectively resolve the association of antitoxin estradiol (E2) levels on human chorionic gonadotropin (hCG) trigger day and live beginning rates (LBRs) in women meeting with fresh embryo transfer and not presenting polycystic ovary syndrome. A total of 13,950 victims who had new embryo transfer between December 2013 and December 2019 were contained. LBR served as the key consequence indicator. After controlling for variables, a multivariable reversion analysis told a significant connection between serum E2 levels on the hCG cause day and LBR [relative risk (RR) 1.027, 95% assurance interval (CI) 1.007, 1.049]. Stratification study revealed thatthe LBR was positively joined (RR 1.052, 95% CI 1.004, 1.102) with all 1 ng/mL increase of serum E2 on the hCG trigger era for the subgroup with reduced antral follicle relies the trigger day. In particular, a two-piecewise uninterrupted regression model showed that when blood E2 content was less than 2.1 ng/mL, skilled was a positive equating (RR 1.188, 95% CI 1.057, 1.334) between antitoxin E2 and LBR with every accretion of 1 ng/mL E2.  However, the relationship betwixt E2 levels and LBR was not statistically significant (RR 1.002, 95% CI 0.971, 1.032) when the level of E2 was higher than the 2.1 ng/mL intonation point. Further prospective studies are necessary to explore the likely mechanisms and to consolidate the friendship between antitoxin E2 levels on the hCG trigger day and LBR.

Author(s) Details:

Xiaoyuan Xu,
Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Aimin Yang,
Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Yan Han,
Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Wei Wang,
Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Guimin Hao,
Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Na Cui,
Department of Reproductive Medicine, Hebei Key Laboratory of Infertility and Genetics, Hebei Clinical Research Center for Birth Defects, Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.

Please see the link here: https://stm.bookpi.org/RDMMS-V8/article/view/10202

Evaluating the Role of Sildenafil on Endometrial Characters in Ovulation Induction Cycle | Chapter 19 | Recent Developments in Medicine and Medical Research Vol. 12

 Sildenafil increases endometrial growth by relaxing the smooth muscles of blood vessels, inducing vasodilation. One of the mainstays of infertility treatment is increasing endometrial thickness. The purpose of this study is to see how Sildenafil affects endometrial characteristics during the ovulation induction cycle.

Materials and Procedures: A total of 50 infertile women with thin endometrium were randomly assigned to one of two groups. 25 women in Group A received clomiphene citrate 50 mg daily from D2 to D6, as well as estradiol valerate 2 mg thrice daily from D2, and 25 women in Group B received clomiphene citrate 50 mg daily from D2 to D6, estradiol valerate 2 mg thrice daily from D2, and sildenafil citrate 25 mg vaginally thrice daily from D7 to the day of ovulation trigger. Trans-vaginal ultrasound was used to evaluate follicular development and endometrial features on alternate days beginning on day 8 of the cycle. An HCG trigger was given once the dominant follicle was >18 mm. In total, three ovulation cycles were investigated.

Endometrial character monitoring demonstrated a considerable improvement in Group B in all ovulation-induced cycles.

The mean endometrial thickness in Group B was 10.21.6 mm versus 8.531.4 mm in Group A; the tri laminar pattern was 93.54 percent in Group B versus 40.29 percent in Group A; the zone 4 endometrium was 79.03 percent in Group B versus 26.86 percent in Group A; and the clinical pregnancy rate per cycle was 20.96 percent in Group B versus 13.45 percent in Group A.

Conclusion: In ovulation induction cycles, the addition of vaginal Sildenafil to estradiol valerate has a substantial effect on endometrial features and clinical pregnancy rates.

Author(S) Details

Alla Satyanarayana Reddy
Department of Obstetrics & Gynaecology, Vinayaka Mission`s Research Foundation (DU), Vinayaka Mission`s Medical College, Karaikal, India.

A. Vikram Arun
Department of Radiology, Vinayaka Mission`s Research Foundation (DU), Vinayaka Mission`s Medical College, Karaikal, India.

View Book:- https://stm.bookpi.org/RDMMR-V12/article/view/4685

Vitamin D deficiency and Its Link with Inflammatory Markers in Women | Chapter 16 |Highlights on Medicine and Medical Science Vol. 2

 Aim: Vitamin D deficiency is a serious health problem that affects people of all ages, particularly elderly women. Menopause is a significant event in a woman's life. Women are becoming more susceptible to a variety of metabolic diseases as they get older. The purpose of this study is to determine serum vitamin D and hs-CRP levels in premenopausal and postmenopausal women.

Methods: The study included 500 female participants, with 400 pre- and postmenopausal women serving as cases and 100 serving as healthy controls. Vitamin D levels in serum were measured using a chemiluminescent microparticle immunoassay, and hs-CRP levels were measured using a latex-enhanced turbidimetric immunoassay. All female subjects were tested for serum estradiol (E2) using a competitive immunoassay method. SPSS software, version 22.0, was used to analyze the data. When pre- and postmenopausal women were compared to healthy control women, vitamin D levels were significantly lower and hs-CRP levels were significantly higher (p0.001). Serum estradiol levels were also significantly lower in postmenopausal women. We discovered a strong negative correlation between vitamin D deficiency and hs-CRP levels in both pre- and postmenopausal women.

Conclusion: Postmenopausal women are more likely than premenopausal women to be vitamin D deficient. Low-grade systemic inflammation has been linked to an increased risk of cardiovascular disease, diabetes, and metabolic syndrome in postmenopausal women.

Author (s) Details

Dr. Deepa Gupta
Department of Biochemistry, NAMO Medical Education & Research Institute, Silvassa, India.

Neelima Singh
University of Kota, Rajasthan, India.

View Book :- https://stm.bookpi.org/HMMS-V2/article/view/1789